Hasaya Dokduang

571 total citations
28 papers, 450 citations indexed

About

Hasaya Dokduang is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Hasaya Dokduang has authored 28 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 12 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Hasaya Dokduang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers), Cancer Mechanisms and Therapy (6 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Hasaya Dokduang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers), Cancer Mechanisms and Therapy (6 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Hasaya Dokduang collaborates with scholars based in Thailand, Japan and United Kingdom. Hasaya Dokduang's co-authors include Watcharin Loilome, Nisana Namwat, Puangrat Yongvanit, Anchalee Techasen, Narong Khuntikeo, Gregory J. Riggins, Anucha Puapairoj, Vajarabhongsa Bhudhisawasdi, Sakkarn Sangkhamanon and Chawalit Pairojkul and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Hasaya Dokduang

24 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hasaya Dokduang Thailand 12 230 199 149 108 78 28 450
Misty Brewer United States 12 261 1.1× 70 0.4× 195 1.3× 110 1.0× 27 0.3× 21 435
Tiemin Pei China 8 240 1.0× 87 0.4× 81 0.5× 115 1.1× 27 0.3× 10 384
Daya Shankar Srivastava India 12 438 1.9× 75 0.4× 47 0.3× 107 1.0× 41 0.5× 22 617
Jichao Wei China 12 300 1.3× 75 0.4× 121 0.8× 179 1.7× 46 0.6× 22 557
Suresh Guruswamy United States 11 411 1.8× 64 0.3× 140 0.9× 54 0.5× 26 0.3× 16 608
Laura Biddick United States 12 189 0.8× 41 0.2× 91 0.6× 70 0.6× 22 0.3× 24 338
Dongwei Jia China 15 344 1.5× 45 0.2× 124 0.8× 136 1.3× 75 1.0× 23 584
Soo Young Jun South Korea 11 293 1.3× 54 0.3× 52 0.3× 156 1.4× 32 0.4× 19 472
Peiyan Hua China 15 367 1.6× 39 0.2× 87 0.6× 199 1.8× 26 0.3× 31 560
Andres I. Roig United States 10 262 1.1× 53 0.3× 166 1.1× 121 1.1× 87 1.1× 13 504

Countries citing papers authored by Hasaya Dokduang

Since Specialization
Citations

This map shows the geographic impact of Hasaya Dokduang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasaya Dokduang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasaya Dokduang more than expected).

Fields of papers citing papers by Hasaya Dokduang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hasaya Dokduang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasaya Dokduang. The network helps show where Hasaya Dokduang may publish in the future.

Co-authorship network of co-authors of Hasaya Dokduang

This figure shows the co-authorship network connecting the top 25 collaborators of Hasaya Dokduang. A scholar is included among the top collaborators of Hasaya Dokduang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hasaya Dokduang. Hasaya Dokduang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Namwat, Nisana, Poramate Klanrit, Arporn Wangwiwatsin, et al.. (2025). Evaluation of Antioxidant and Anti-Aging Activities of Thai Rice Germ Extracts. Trends in Sciences. 22(4). 9348–9348.
2.
Loilome, Watcharin, et al.. (2025). Antioxidative and anticancer effects of Tacca chantrieri extract enhancing cisplatin sensitivity in cholangiocarcinoma cells. PLoS ONE. 20(1). e0317111–e0317111. 2 indexed citations
3.
Jusakul, Apinya, Nisana Namwat, Poramate Klanrit, et al.. (2025). Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma. Scientific Reports. 15(1). 10886–10886. 2 indexed citations
4.
Dokduang, Hasaya, Watcharin Loilome, Nisana Namwat, et al.. (2025). Characterization and identification of extrachromosomal circular DNA in cholangiocarcinoma. PLoS ONE. 20(5). e0322173–e0322173.
5.
Phetcharaburanin, Jutarop, Hasaya Dokduang, Watcharin Loilome, et al.. (2025). Metabolomic analysis of bioactive compounds in dill (Anethum graveolens L.) extracts. PeerJ. 13. e19567–e19567.
6.
Wangwiwatsin, Arporn, Nisana Namwat, Poramate Klanrit, et al.. (2025). Mitochondrial genomic alterations in cholangiocarcinoma cell lines. PLoS ONE. 20(6). e0323844–e0323844.
7.
8.
Roytrakul, Sittiruk, Nisana Namwat, Poramate Klanrit, et al.. (2025). Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma. Scientific Reports. 15(1). 17228–17228. 1 indexed citations
9.
Dokduang, Hasaya, et al.. (2024). Antioxidant and longevity inducing properties of coconut water on human dermal fibroblasts. Heliyon. 10(24). e41010–e41010. 1 indexed citations
10.
Dokduang, Hasaya, Nisana Namwat, Poramate Klanrit, et al.. (2021). Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression. Frontiers in Pharmacology. 12. 696961–696961. 25 indexed citations
11.
Phetcharaburanin, Jutarop, Nisana Namwat, Poramate Klanrit, et al.. (2021). Metabolic Profiling of Praziquantel-mediated Prevention ofOpisthorchis viverrini-induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma. Cancer Genomics & Proteomics. 18(1). 29–42. 5 indexed citations
12.
Thanee, Malinee, Hasaya Dokduang, Jutarop Phetcharaburanin, et al.. (2021). CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression. PLoS ONE. 16(3). e0245871–e0245871. 13 indexed citations
13.
Thanee, Malinee, Hasaya Dokduang, Jutarop Phetcharaburanin, et al.. (2021). Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. SHILAP Revista de lepidopterología. 9(1). 11–11. 20 indexed citations
14.
Loilome, Watcharin, et al.. (2021). Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma. Expert Opinion on Investigational Drugs. 30(9). 985–1006. 3 indexed citations
15.
Dokduang, Hasaya, Malinee Thanee, Jutarop Phetcharaburanin, et al.. (2020). In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Dokduang, Hasaya, Anchalee Techasen, Nisana Namwat, et al.. (2018). Inhibitory effect of NVP‑BKM120 on cholangiocarcinoma cell growth. Oncology Letters. 16(2). 1627–1633. 8 indexed citations
17.
Thongchot, Suyanee, Hasaya Dokduang, Watcharin Loilome, et al.. (2016). Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma. Anticancer Research. 36(11). 5981–5988. 11 indexed citations
18.
Dokduang, Hasaya, Puangrat Yongvanit, Nisana Namwat, et al.. (2016). Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells. Oncology Reports. 35(4). 2065–2072. 29 indexed citations
19.
Techasen, Anchalee, et al.. (2012). Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells.. PubMed. 13 Suppl. 115–8. 52 indexed citations
20.
Dokduang, Hasaya, Nisana Namwat, Apinya Jusakul, et al.. (2010). Determination of Growth Inhibitory Effect of Gemcitabine on Human Intrahepatic Cholangiocarcinoma Cell lines and Comparison of its Inhibition Between the Generic and Reference Formulation. Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร. 25(1). 2–5. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Misty Brewer Breakdown of academic impact, for papers by Tiemin Pei Breakdown of academic impact, for papers by Daya Shankar Srivastava Breakdown of academic impact, for papers by Jichao Wei Breakdown of academic impact, for papers by Suresh Guruswamy Breakdown of academic impact, for papers by Laura Biddick Breakdown of academic impact, for papers by Dongwei Jia Breakdown of academic impact, for papers by Soo Young Jun Breakdown of academic impact, for papers by Peiyan Hua Breakdown of academic impact, for papers by Andres I. Roig
Rankless by CCL
2026